Clinical Trial Update: Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032) [Phase 1]

View source ↗

Summary

Phase 1 trial update on the effects of suvorexant in patients with chronic obstructive pulmonary disease (MK-4305-032) completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Insomnia

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Insomnia | Phase 1 | Status: COMPLETED | Results posted: 2014-09-10